Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Edgewise Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19
Revenues0.00.08.6
            Revenue growth -100.0% 
Cost of goods sold0.00.09.9
Gross profit0.00.0-1.3
            Gross margin  -15.1%
Research and development32.215.0 
General and administrative11.02.21.3
EBIT-43.2-17.2-9.9
            EBIT margin  -115.1%
Pre-tax income-42.8-17.10.0
Income taxes0.00.00.0
            Tax rate0.0%0.0% 
Net income-42.8-17.10.0
            Net margin  0.0%
 
Diluted EPS($1.14)($23.17)$0.00
Shares outstanding (diluted)37.50.7377.8
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy